Silence Therapeutics PLC at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thank you for joining Day 3 of Needham's 20th Annual Healthcare Conference. My name is Vincent Kover, I sit on Needham's institutional equities team. I have the pleasure this morning of introducing Silence Therapeutics. They are a $673 million market cap company, who trade under the symbol SLN. We have Mark Rothera with us, who is the President and CEO. We'll also be joined later on after the presentation by Craig Tooman and Giles Campion for our Q&A.
Once Mark is finished with the presentation, we'll move into about a 10-minute Q&A. Please feel free to use the text box underneath your screen to enter any questions over the course of the presentation.
Mark, thank you so much for joining us today. I'll turn the floor over to you.
Vincent, thank you very much for the invitation. Good morning to all those participating in the U.S. Good afternoon to those who are in the U.K., as I am today.
So Silence is a well
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
